ResMed Inc. (ASX: RMD) - ETF Exposure
Current share price for RMD : $31.580 0.12 (0.38%)+
ResMed Inc (RMD) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It works to increase awareness of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. The company provides diagnoses and develops treatments for these conditions for people worldwide.
RMD General Information +
| ASX Code | RMD |
| Website | N/A |
| Industry/Sector | Health Care Equipment |
| Market Cap ($M) | 18,351 |
| RMD Share Price | $31.580 |
| Day High | $31.790 |
| Day Low | $31.490 |
| Last Close | $31.700 |
| RMD Share Price Movement | $0.12 ( 0.38% ) |
Prices as at 16:40, 25 Sep 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Already own an Australian ETF? You may already have meaningful exposure to RMD
As one of Australia's largest companies by market capitalisation, RMD is held across 33 ETFs spanning strategies that include health care equipment exposure . Its weighting in those funds means performance can have an outsized influence - when RMD moves, funds like LNYN, XX20, AEAE, INIF and INES that hold it can move with it.
For more concentrated exposure, ETFs such as LNYN (Lanyon Investment Fund Active ETF) allocate about 5.9% to RMD , while the average exposure across all 33 ETFs that hold it is around 2% .
Top ETF holdings
- Lanyon Investment Fund Active ETF (LNYN) ~ 5.9%
- First Sentier EX-20 Australian Share Active ETF (XX20) ~ 5.5%
- Australian Ethical High Conviction Fund - Active ETF (AEAE) ~ 5.2%
- Intelligent Investor Aus Equity Income Fund (Managed Fund) (INIF) ~ 4.9%
- Intelligent Investor Ethical Share Fund (Managed Fund) (INES) ~ 4.6%
Last updated: ETF data and holdings as at 26 September 2026
Own RMD directly or through an ETF?
How does holding ResMed Inc. (RMD) shares directly compare to ETFs that include it?
|
RMD Direct
|
LNYN
ASX |
XX20
ASX |
AEAE
CBOE |
INIF
ASX |
INES
ASX |
|
|---|---|---|---|---|---|---|
| Holdings | 1 company | 40 holdings | 29 holdings | 32 holdings | 21 holdings | 22 holdings |
| RMD Weight | 100% | 5.9% | 5.5% | 5.2% | 4.9% | 4.6% |
| Diversification | Single Stock | Broad | Broad | Broad | Broad | Broad |
| Annual Cost | Brokerage only | 1% p.a. | 0.75% p.a. | 0.69% p.a. | 0.97% p.a. | 0.97% p.a. |
| Approx. Yield | 1.2% | 1.01% | 1.45% | - | 12.17% | 8.57% |
| Star Ratings | - |  |
|
|
|
|
Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not RMD's direct yield. Annual cost uses each ETF's MER.
RMD Exposure on $10,000 investment
How a $10,000 investment in ResMed Inc. (RMD) one week ago compares with ETFs that hold it.
| Security | Investment type | Current price | 7-day price movement | Dollar change | Value today |
|---|---|---|---|---|---|
| ResMed Inc. (RMD) | Direct share | $31.580 | -0.91% | -$91 | $9,909 |
| Lanyon Investment Fund Active ETF (LNYN) | Equity - Global Strategy | $1.880 | -1.05% | -$105 | $9,895 |
| First Sentier EX-20 Australian Share Active ETF (XX20) | Equity - Australia Strategy | $1.215 | -1.62% | -$162 | $9,838 |
| Australian Ethical High Conviction Fund - Active ETF (AEAE) | Equity - Australia Strategy | $9.300 | -1.17% | -$117 | $9,883 |
| Intelligent Investor Aus Equity Income Fund (Managed Fund) (INIF) | Equity - Australia Strategy | $2.680 | -1.47% | -$147 | $9,853 |
| Intelligent Investor Ethical Share Fund (Managed Fund) (INES) | Equity - Australia Strategy | $3.090 | -2.22% | -$222 | $9,778 |
Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.
ResMed Inc. (RMD) ETFs
33 ETFs hold ResMed Inc. (RMD).
| ETF | RMD Weight | MER | Yield |
|---|---|---|---|
| Lanyon Investment Fund Active ETF (LNYN) | 5.9% | 1% | 1.01% |
| First Sentier EX-20 Australian Share Active ETF (XX20) | 5.5% | 0.75% | 1.45% |
| Australian Ethical High Conviction Fund - Active ETF (AEAE) | 5.2% | 0.69% | - |
| Intelligent Investor Aus Equity Income Fund (Managed Fund) (INIF) | 4.9% | 0.97% | 12.17% |
| Intelligent Investor Ethical Share Fund (Managed Fund) (INES) | 4.6% | 0.97% | 8.57% |
| Intelligent Investor Australian Equity Growth Fund (Managed Fund) (IIGF) | 4.4% | 0.97% | 8% |
| Intelligent Investor Select Value Share Fund (Managed Fund) (IISV) | 4.3% | 0.97% | 11.52% |
| First Sentier Geared Australian Share Fund Complex ETF (LEVR) | 3.5% | 2.38% | 0.66% |
| AB Managed Volatility Equities Fund - MVE Class - Active ETF (AMVE) | 3.4% | 0.55% | - |
| BetaShares Australian Sustainability Leaders ETF (FAIR) | 3.3% | 0.49% | 3.2% |
ResMed Inc. (RMD) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| HFResult | 6.5¢ | 0% | 19 Aug 2026 | 24 Sep 2026 | - | - | - |
| Result | 5.82¢ | 0% | 13 May 2026 | 18 Jun 2026 | - | - | - |
| Result | 5.92¢ | 0% | 11 Feb 2026 | 19 Mar 2026 | - | - | - |
See all dividends from ResMed Inc. (RMD) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
ResMed Inc. (RMD) price-sensitive announcements
RMD - Resmed Form 10-K Annual Report
ResMed Inc.'s Form 10-K Annual Report for the fiscal year ended June 30, 2026, highlights
ResMed Inc. (RMD)
14 Aug 2026 | 8:32 AM
14 Aug 2026 | 8:32 AM
RMD - Dividend/Distribution - RMD
ResMed Inc. has announced a dividend distribution for holders of Chess Depositary Instrume
ResMed Inc. (RMD)
7 Aug 2026 | 8:27 AM
7 Aug 2026 | 8:27 AM
RMD - Resmed Announces Results for the Fourth Quarter of FY2026
ResMed Inc. announced strong financial results for the fourth quarter of fiscal year 2026,
ResMed Inc. (RMD)
7 Aug 2026 | 8:26 AM
7 Aug 2026 | 8:26 AM
RMD - Resmed Announces Agreement to Sell MatrixCare Business
ResMed Inc. announced an agreement to sell its MatrixCare business to Frazier Healthcare P
ResMed Inc. (RMD)
8 Jul 2026 | 8:24 AM
8 Jul 2026 | 8:24 AM
ResMed Inc. (RMD) Recent ASX Announcements
RMD Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026F | $2,235.46 | $151.45 | 10.20% | 25.03 | 44.61 | 1.18% | 0.0% |
| 2025F | $2,028.91 | $137.46 | 16.70% | 27.58 | 34.38 | 0.91% | 0.0% |
| 2024A | $1,737.52 | $117.75 | 23.10% | 23.39 | 30.04 | 1.09% | 0.0% |
RMD Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | ||
| Cochlear Limited (COH) | $9,339M | -0.3136 | 0.2540 | 0.0785 | 34.7657 | 27.7238 | 25.7061 | 2.42% | 2.51% | 2.73% |
| Fisher & Paykel Healthcare Corporation Limited (FPH) | $21,242M | 0.1388 | 0.1545 | 0.1574 | 54.6046 | 47.2954 | 40.8623 | 1.20% | 1.31% | 1.45% |
| Imricor Medical Systems Inc (IMR) | $617M | -0.4254 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| ResMed Inc. (RMD) | $18,421M | 9.5922 | 0.0986 | 0.0915 | 20.5831 | 18.7363 | 17.1658 | 1.13% | 1.23% | 1.32% |
RMD Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Michael J Farrell | Chief Executive Officer, Executive Director | 1 Mar 2013 |
| Mr Ronald R Taylor | Non-Executive Director | 25 Jan 2005 |
| Ms Carol Burt | Non-Executive Director | 11 Aug 2014 |
| Ms Karen Ruth Drexler | Non-Executive Director | 17 Nov 2017 |
| Mr Jan De Witte | Non-Executive Director | 16 May 2019 |
| Ms Harjit Gill | Non-Executive Director | 15 Nov 2018 |
| Dr John Hernandez | Non-Executive Director | 19 Nov 2021 |
| Dr Desney Tan | Non-Executive Director | 19 Nov 2021 |
| Mr Christopher DelOrefice | Non-Executive Director | 19 Aug 2024 |
| Ms Nicole Mowad Nassar | Non-Executive Director | 15 Aug 2025 |
| Dr Peter Craig Farrell | Non-Executive Director, Non-Executive Chairman | 1 Jul 2002 |
ResMed Inc. (RMD) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 2 Jul 2024 | ROBERTS, Christopher | Issued | Options | 12,000 | $50.950 | $611,400.000 |
| 19 Aug 2011 | FARRELL, Peter | Sell | Direct Shares | 200,000 | $0.000 | |
| 17 Aug 2011 | FARRELL, Peter | Issued | Related Securities | 28,571 | $0.000 |
See all changes in directors' interest & trades for ResMed Inc. (RMD) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
RMD Management
| Name | Position |
|---|---|
| Aaron Bloomer | CFO (Principal Financial Officer and Principal Accounting Officer) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
